TruAlt Bioenergy Share Price Today (TRUALT)
TODAY IN ONE LINE
TRUALT slipped 0.7% on light volume, in line with Nifty's -0.4% move.
With a market cap of ₹3,681.79 Cr., it trades at a P/E of 38.30. Track live valuations, technical indicators, and peers comparison below. Check delivery conviction and recent filings to build your view.
How good is this company?
Overall performance across 5 key dimensions.
TruAlt Bioenergy flags & news
Key strengths, potential risks, and recent updates.
Green Flags
- ●Healthy Operating MarginsOPM is structurally strong at 16.8%
- ●High Promoter HoldingPromoters hold 70.6% skin-in-the-game
Red Flags
- ●Earnings DeclineEPS (TTM) has contracted by 55.8% YoY
- ●Sales ContractionQuarterly sales dropped 34.3% YoY
- ●Poor Capital ReturnsLow ROE of 8.4%
- ●Promoter Pledging DetectedPledge activity recorded on 12-Nov-2025 19:38
Latest TruAlt Bioenergy News
What changed recently?
Recent events, corporate actions, and announcements.
TruAlt Bioenergy Ltd valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for TruAlt Bioenergy Ltd, framed against the sector median so the premium or discount is obvious at a glance.
TruAlt Bioenergy Ltd trades at a P/E of 38.30× and P/B of 2.42×.
Market-priced ratios use the latest available quote; accounting metrics use the latest reported filing. Compare values with matched peers and the company's own history.
Valuation
Profitability
Growth
Financial Health
TruAlt Bioenergy Ltd technical analysis: indicators, pivots and CPR.
Live RSI, MACD and moving-average signals plus today's pivot and Central Pivot Range levels for TruAlt Bioenergy Ltd — derived from the live tape, not yesterday's close.
TruAlt Bioenergy Ltd last traded at ₹428.95 with an intraday range of ₹426.5–₹439 — live indicator, pivot and CPR signals below.
Pivot points
Standard pivot — most widely referenced.
Pivot levels · Classic
Live: ₹428.95| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 461.47 | +32.52 | +7.58% |
| R3 | 448.97 | +20.02 | +4.67% |
| R2 | 443.98 | +15.03 | +3.50% |
| R1 | 436.47 | +7.52 | +1.75% |
| PIVOT | 431.48 | 2.53 | 0.59% |
| CURRENT | 428.95 | — | — |
| S1 | 423.97 | -4.98 | -1.16% |
| S2 | 418.98 | -9.97 | -2.32% |
| S3 | 411.47 | -17.48 | -4.08% |
| S4 | 398.97 | -29.98 | -6.99% |
TRUALT is trading Below CPR, indicating Bearishness
CPR is Wider, suggesting unlikely for trending moves
Day's range: ₹430–₹438.7
Trading Inside opening range
TruAlt Bioenergy Ltd financials: P&L, balance sheet, cash flow, ratios.
Reported annual and quarterly results for TruAlt Bioenergy Ltd — consolidated or standalone — with margins, YoY growth and key ratios inline.
TruAlt Bioenergy Ltd reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹3,681.79 Cr. and reported EPS of ₹11.20.
| Metric | — | Mar 2026 |
|---|---|---|
| Revenue from Operations | — | 1,728 |
| Other Income | — | 86 |
| Total Income | — | 1,814 |
| — | 1,114 | |
| Gross ProfitDerived | — | 613 |
| Gross Margin %Derived | — | 35.49% |
| — | 323 | |
| EBITDA (Operating Profit)Derived | — | 290 |
| OPM %Derived | — | 16.77% |
| — | 246 | |
| Profit Before Tax (PBT) | — | 130 |
| — | 33 | |
| Effective Tax %Derived | — | 25.46% |
| Total Profit for Period | — | 97 |
| Less: Non-controlling Interests | — | 1 |
| Net Profit (Owner's PAT)Derived | — | 96 |
| Net Profit Margin %Derived | — | 5.55% |
| Earnings Per Share (EPS ₹) | — | 11.19 |
| Diluted Shares Outstanding (Cr) | — | 9 |
| Other Comprehensive Income (Net of Tax) | — | 0 |
| Total Expenses (incl. D&A & Interest) | — | 1,684 |
| Material Cost % of RevenueDerived | — | 61.21% |
| Employee Cost % of RevenueDerived | — | 2.77% |
| Other Cost % of RevenueDerived | — | 15.95% |
| Interest Coverage (x)Derived | — | 1.27x |
| Period | Mar 2026 | Trend |
|---|---|---|
| Revenue from Operations | 1,728 | |
| Other Income | 86 | |
| Total Income | 1,814 | |
1,114 | ||
| Gross ProfitDerived | 613 | |
| Gross Margin %Derived | 35.49% | |
323 | ||
| EBITDA (Operating Profit)Derived | 290 | |
| OPM %Derived | 16.77% | |
246 | ||
| Profit Before Tax (PBT) | 130 | |
33 | ||
| Effective Tax %Derived | 25.46% | |
| Total Profit for Period | 97 | |
| Less: Non-controlling Interests | 1 | |
| Net Profit (Owner's PAT)Derived | 96 | |
| Net Profit Margin %Derived | 5.55% | |
| Earnings Per Share (EPS ₹) | 11.19 | |
| Diluted Shares Outstanding (Cr) | 9 | |
| Other Comprehensive Income (Net of Tax) | 0 | |
| Total Expenses (incl. D&A & Interest) | 1,684 | |
| Material Cost % of RevenueDerived | 61.21% | |
| Employee Cost % of RevenueDerived | 2.77% | |
| Other Cost % of RevenueDerived | 15.95% | |
| Interest Coverage (x)Derived | 1.27x |
TruAlt Bioenergy segment analysis : revenue and profit mix.
Disclosed business segments at TruAlt Bioenergy with their share of revenue and profit, switchable between consolidated and standalone reporting.
TruAlt Bioenergy discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
The Bull, Bear, and Flip case for TruAlt Bioenergy Ltd.
Our AI distills the core fundamental drivers supporting TruAlt Bioenergy Ltd, the risks that threaten it, and the quantitative conditions that could weaken the thesis.
TruAlt Bioenergy Ltd's investment case rests on 10 positive markers and 10 flagged concerns drawn from the latest reported filings.
What you're getting.
Operating margin 11.78% demonstrates solid cost control and operational efficiency.
Promoter holding 70.6% ensures strong management alignment and long-term strategic commitment.
Net margin 12.06% TTM supports earnings quality and operational discipline despite recent headwinds.
Low beta 0.74 indicates moderate volatility suitable for risk-averse investor portfolios.
EV/FCF 3.32x signals potential undervaluation relative to free cash flow generation capacity.
Key Risks.
Latest quarterly EPS declined 46.4% YoY, signaling deteriorating earnings momentum severely.
TTM EPS declined 55.8% YoY, indicating severe earnings weakness and profitability erosion.
Debt-to-equity 1.09x reflects extreme leverage and elevated financial risk exposure critically.
Operating cash flow negative ₹289.65 Cr signals acute liquidity concerns and cash burn.
Zero dividend yield limits income appeal for dividend-seeking investors seeking regular returns.
Flip Conditions.
Valuation risk. a P/E above 50 would leave less room for earnings disappointment.
Reassess if quarterly profit growth turns negative for two consecutive quarters. The bull case relies on compounding earnings.
Watch interest coverage if debt-to-equity climbs above 109.50. Balance sheet risk re-prices growth multiples fast.
Return-quality risk. ROE below 8% would indicate weaker capital compounding.
TruAlt Bioenergy Ltd peer comparison — same-sector benchmarks.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — TruAlt Bioenergy Ltd is highlighted for quick read-across.
Quick Compare
Peer Comparison
| Company Name |
|---|
TruAlt Bioenergy Ltd chart patterns: breakouts, tops and bottoms.
Auto-detected classical chart patterns for TruAlt Bioenergy Ltd — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.
- 1Pick how to scan. Detection sets sensitivity — Daily (standard) → Weekly (big swings). History sets how far back to look.
- 2Read the summary. The tiles at the top give the current read: net bias, the strongest pattern, and the one nearest to triggering.
- 3Scan the list. Use the Actionable, Watchlist, and History tabs to browse patterns. Click a pattern card to focus it.
- 4Inspect on the chart. Focusing draws the pattern’s pivots plus its break (blue), target (amber) and invalidation lines.
- 5Filter to what matters. Use the status controls (Confirmed, Forming, Invalidated) to hide noise and find exactly what you are looking for.
Pattern history — every completed pattern and its outcome
TruAlt Bioenergy Ltd delivery volume — last 20 sessions of conviction.
Daily traded volume and delivery percentage for TruAlt Bioenergy Ltd over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in TruAlt Bioenergy Ltd stood at 37.1% of traded volume, against a 20-day average of 51.7%.
TruAlt Bioenergy announcements: results, concalls, ratings, M&A.
Filings TruAlt Bioenergy sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
TruAlt Bioenergy files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 58 documents below.
Shareholders meeting
TruAlt Bioenergy Limited has informed the Exchange regarding Proceedings of Postal Ballot. Further, the company has informed the Exchange regarding…
Certificate under SEBI (Depositories and Participants) Regulations, 2018
TruAlt Bioenergy Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
Trading Window
TruAlt Bioenergy Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading)…
Disclosure under SEBI Takeover Regulations
Vijaykumar Murugesh Nirani has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India…
Copy of Newspaper Publication
The Company has published newspaper advertisements regarding the Postal Ballot Notice in Financial Express and Vishwavani on June 9, 2026, following…
Investor decks & rating reports.
TruAlt Bioenergy dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue TruAlt Bioenergy has declared, sequenced by announce and record date.
TruAlt Bioenergy corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
About TruAlt Bioenergy Ltd: business, sector, key facts.
What TruAlt Bioenergy Ltd does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
TruAlt Bioenergy Ltd operates in the Other Agricultural Products industry under the Fast Moving Consumer Goods sector.
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
- Ajooni Biotech (AJOONI) Share PricePeer
- Amir Chand Jagdish Kumar (Exports) (AMIRCHAND) Share PricePeer
- B & A (BNALTD) Share PricePeer
- Bombay Super Hybrid Seeds (BSHSL) Share PricePeer
- Comfort Intech (COMFINTE) Share PricePeer
- Top Gainers TodayScreener
- EMA Crossover ScreenerScreener
- Stock Quality ScorecardScreener
- Technical DashboardScreener
- Results CalendarScreener
- FII Buying ActivityScreener
- All Technical ScreenersScreener
- All Trading StrategiesStrategy
Questions investors ask about TruAlt Bioenergy Ltd (TRUALT).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of TruAlt Bioenergy Ltd (TRUALT)?
The current share price of TruAlt Bioenergy Ltd (TRUALT) is ₹428.95. Today, the stock has declined by ₹2.95 (0.68%), trading in a range of ₹426.5 to ₹439. The stock opened at ₹430 with a trading volume of 2,87,154 shares.
02Is TruAlt Bioenergy Ltd stock a good investment for long-term?
TruAlt Bioenergy Ltd can be considered for long-term investment based on several factors. The company has a market capitalization of ₹3,681.79 crores, P/E ratio of 38.30, ROE of 8.38%, and ROCE of 10.40%. The dividend yield stands at 0.00%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
03What is the 52-week high and low price of TruAlt Bioenergy Ltd stock?
The 52-week high price of TruAlt Bioenergy Ltd (TRUALT) is ₹549, while the 52-week low is ₹310.2. Currently trading at ₹428.95, the stock is 49.7% away from its 52-week low and 21.9% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
04Should I buy TruAlt Bioenergy Ltd stock at the current price?
Whether to buy TruAlt Bioenergy Ltd stock at ₹428.95 depends on multiple factors. The stock is currently trading with a P/E ratio of 38.30 and P/B ratio of 2.42. Today's performance shows a loss of 0.68%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
05What is the dividend yield of TruAlt Bioenergy Ltd and when is the next dividend?
TruAlt Bioenergy Ltd offers a dividend yield of 0.00%, which means for every ₹100 invested at the current price of ₹428.95, you can expect to receive approximately ₹0.00 annually as dividends. The face value of the stock is ₹10.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
06What are the key financial ratios and metrics of TruAlt Bioenergy Ltd?
TruAlt Bioenergy Ltd's key financial metrics include: P/E Ratio: 38.30, P/B Ratio: 2.42, ROE: 8.38%, ROCE: 10.40%, Dividend Yield: 0.00%, EPS: ₹11.20, Book Value: ₹177, and Debt-to-Equity: 109.00. The company's market cap stands at ₹3,681.79 crores. These metrics help evaluate the company's valuation, profitability, and financial health.
07How is TruAlt Bioenergy Ltd stock performing today in the market?
TruAlt Bioenergy Ltd stock opened at ₹430 and is currently trading at ₹428.95, showing a decline of ₹2.95 (0.68%). The intraday high is ₹439 and low is ₹426.5. The trading volume stands at 2,87,154 shares, indicating moderate market participation today.
08What is the P/E ratio of TruAlt Bioenergy Ltd and what does it indicate?
TruAlt Bioenergy Ltd has a Price-to-Earnings (P/E) ratio of 38.30, which means investors are willing to pay ₹38.30 for every ₹1 of earnings. With an EPS of ₹11.20, this P/E ratio suggests the stock may be trading at a premium, possibly due to high growth expectations. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about TruAlt Bioenergy Ltd (TRUALT) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.